Directed differentiation was carried out using H9 cells without or with pre-treatment of 0.0064% DMSO (Sigma-Aldrich, Munich, Germany) or 10 nM TCDD (Cambridge Isotope Laboratories, Tewksbury, MA, USA) in mTESR™1 medium for 3 days. Cells were washed with PBS and harvested by GCDR (Gentle Cell Dissociation Reagent, STEMCELL Technologies) and incubated at 37 °C for 8 min in 5% CO2. Single cell suspensions were generated by gentle pipetting and added to 1 mL KnockOut™ DMEM (Dulbecco’s modified Eagle medium, Thermo Fisher Scientific, Rockford, IL, USA). Remaining cells were gathered by washing the wells with 1 mL fresh KnockOut™ D-MEM. Cells were then centrifuged at 300× g for 5 min and resuspended in medium with 10 µM ROCK (Rho-associated protein kinase, Bio-Techne, Minneapolis, MN, USA) inhibitor. Cells were counted using Countess II cell counter (Thermo Fisher Scientific) and transferred to Matrigel™-coated 6-well plates. For neural differentiation, STEMdiff™ neural induction medium (STEMCELL Technologies) was used. Cells were differentiated for 7 days with daily medium changes according to the manufacturer’s protocol. Pre-treated hESCs were differentiated in the presence of DMSO or 10 nM TCDD. For mesodermal and endodermal differentiation, cells were initially plated in mTESR™1. The next day, medium was changed to STEMdiff™ Mesodermal Induction Medium or STEMdiff™ Definite Endoderm Kit Medium (both STEMCELL Technologies), respectively. Cells were differentiated for 5 days with daily medium changes according to the manufacturer’s protocol. Pre-treated hESCs were differentiated in the presence of DMSO or 10 nM TCDD. Plating densities are shown in Figure S14.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.